Year 2012, Volume 42, Issue 3, Pages 411 - 415 2012-03-01

A comparative investigation of anti-Müllerian hormone (AMH) and various biochemical parameters in patients with cryptorchidism, oligospermia, or varicocele*
A comparative investigation of anti-Müllerian hormone (AMH) and various biochemical parameters in patients with cryptorchidism, oligospermia, or varicocele*

Turan AKDAĞ [1] , Ali Muhtar TİFTİK [2] , Levent SARIYILDIZ [3]

124 588

To investigate the serum AMH and various biochemical parameter levels in patients with cryptorchidism, oligospermia, or varicocele. Materials and methods: This study included 100 participants, divided into 5 groups: cryptorchidism (n = 20), varicocele (n = 20), oligospermia (n = 20), and 2 control groups [control 1, 8-12 years old (n = 20) and control 2, 18-24 years old (n= 20)]. Using the blood samples drawn from both patient and control groups, AMH, testosterone, FSH, LH, and prolactin parameters were investigated. Results: AMH values measured were found to be 73.04 ± 44.5 ng/mL and 84.81 ± 59.1 ng/mL in 20 children with cryptorchidism and 20 healthy children (both groups aged between 8 and 12 years), respectively (P = 0.56). In the present study, AMH values were found to be 5.19 ± 4.9 ng/mL and 7.66 ± 5.6 ng/mL in 20 patients with oligospermia and 20 healthy individuals (both groups aged between 18 and 24 years), respectively (P = 0.10). AMH values in 20 patients with varicocele and 20 healthy controls aged between 18 and 24 years were determined to be 7.15 ± 5.8 ng/mL and 7.66 ± 5.6 ng/mL, respectively (P = 0.82). No significant P values were determined, but the decrease in values was remarkable. Conclusion: New studies with larger number of participants are needed in order to determinate AMH levels in patients with varicocele, cryptorchidism, or varicocele for diagnostic criteria.
To investigate the serum AMH and various biochemical parameter levels in patients with cryptorchidism, oligospermia, or varicocele. Materials and methods: This study included 100 participants, divided into 5 groups: cryptorchidism (n = 20), varicocele (n = 20), oligospermia (n = 20), and 2 control groups [control 1, 8-12 years old (n = 20) and control 2, 18-24 years old (n= 20)]. Using the blood samples drawn from both patient and control groups, AMH, testosterone, FSH, LH, and prolactin parameters were investigated. Results: AMH values measured were found to be 73.04 ± 44.5 ng/mL and 84.81 ± 59.1 ng/mL in 20 children with cryptorchidism and 20 healthy children (both groups aged between 8 and 12 years), respectively (P = 0.56). In the present study, AMH values were found to be 5.19 ± 4.9 ng/mL and 7.66 ± 5.6 ng/mL in 20 patients with oligospermia and 20 healthy individuals (both groups aged between 18 and 24 years), respectively (P = 0.10). AMH values in 20 patients with varicocele and 20 healthy controls aged between 18 and 24 years were determined to be 7.15 ± 5.8 ng/mL and 7.66 ± 5.6 ng/mL, respectively (P = 0.82). No significant P values were determined, but the decrease in values was remarkable. Conclusion: New studies with larger number of participants are needed in order to determinate AMH levels in patients with varicocele, cryptorchidism, or varicocele for diagnostic criteria.
  • Massague J. Th e transforming growth factor-beta family. Annu Rev Cell Biol 1990; 6: 597-641.
  • Rajpert-De ME, Jorgensen N, Graem N, Müller J, Cate RL, Skakkebaek NE. Expression of anti-Müllerian hormone during normal and pathological gonadal development: association with diff erentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab 1999; 84: 3836-3844.
  • Rodolfo R. Anti-Müllerian hormone in disorders of sex determination and diff erentiation. Arq Bras Endocrinol Metab 2005; 49: 26-36.
  • AH Lane, PK Donahoe. New insights into Mullerian inhibiting substance and its mechanism of action. J Endocrinol 1998; 158: 1-6.
  • Kumar A, Karla B, Patel A, McDavid L, Roudebush WE. Development of a second generation Anti-Müllerian hormone (AMH) ELISA. J Immunol Methods 2010; 362: 51-59.
  • Al-Qahtani A, Muttukrishna S, Appasamy M, Johns J, Cranfi eld M, Visser JA et al. Development of a sensitive enzyme immunoassay for anti-Müllerian hormone and the evaluation of potential clinical applications in males and females. Clin Endocrinol 2005; 63: 267-273. 7. Grinspon RP, Rey RA. Anti-müllerian hormone and sertoli cell function in pediatric male hypogonadism. Horm Res Paediatr 2010; 73: 81-92.
  • Josso N, Racine C, di Clemente N, Rey R, Xavier F. Th e role of anti-Müllerian hormone in gonadal development. Mol Cell Endocrinol 1998; 145: 3-7.
  • Griffi n JE, Ojeda S. Textbook of Endocrinology. New York: Oxford University Press; 1988.
  • Goodman MH. Basic Medical Endocrinology. 3rd ed. USA: Elsevier Science; 1988.
  • Serge N, Luis FP.Hormones in male sexual development. Genes Dev 2000; 14: 3075-3086.
  • Aksglaede L, Sİrensen K, Boas M, Mouritsen A, Hagen C, Jensen R et al. Changes in Anti-Müllerian Hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. J Clin Endocrinol & Metabol 2010; 95: 5357-5364.
  • Josso N, Boussin L, Knebelmann B, Nihoul-Fékété C, Picard JY. Anti-Müllerian hormone and intersex states. Trends Endocrinol Metabol 1991; 2: 227-233.
  • Josso N, Racine C, di Clemente N, Rey R, Xavie r F. Th e role of anti-Müllerian hormone in gonadal development. Mol Cell Endocrinol 1998; 145: 1-2.
  • World Health Organization. Laboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus Interaction. 4th ed. New York: Cambridge University Press; 1999.
  • Wackerly D, Mendenhall W, Scheaff er RL. Mathematical Statistics with Applications. USA: Th omson Learn; 2002.
  • Lee MM, Misra M, Donahoe PK, MacLaughlin DT. MIS/AMH in the assessment of cryptorchidism and intersex conditions. Mol Cell Endocrinol 2003; 211: 91-8.
  • Demircan M, Akinci A, Mutus M. Th e eff ects of orchiopexy on serum anti-Müllerian hormone levels in unilateral cryptorchid infants. Pediatr Surg Int 2006; 22: 271–3.
  • Rey R, Lordereau-Richard I, Carel JC, Barbet P, Cate RL, Roger M et al. Anti-Müllerian hormone and testosterone serum levels are inversely during normal and precocious pubertal development. J Clin Endocrinol Metab 1993; 77: 1220-6.
  • Yamanaka J, Baker M, Metcalfe S, Hutson JM. Serum levels of Mullerian inhibiting substance in boys with cryptorchidism. J Pediatr Surg 1991; 26: 621-3.
  • Najiba L, Ilene F, Jean-Claude C, Marc R. Inhibin B and Anti- Müllerian hormone, but not testosterone levels, are normal in infants with nonmosaic Klinefelter syndrome. J Clin Endocrinol & Metabol 2004: 89; 1864-1868.
  • Baker ML, Metcalfe SA, Hutson JM. Serum levels of Müllerian inhibiting substance in boys from birth to 18 years, as determined by enzyme immunoassay. J Clin Endocrinol Metabol 1990; 70: 11-5.
  • Trigo RV, Bergadá I, Rey R, Ballerini MG, Bedecarrás P, Bergadá C et al. Altered serum profi le of inhibin B, Pro-alpha C and anti-Müllerian hormone in prepubertal and pubertal boys with varicocele. Clin Endocrinol 2004; 60: 758-64.
  • Pierik FH, Burdorf A, de Jong FH, Weber RF. Inhibin B: a novel marker of spermatogenesis. Ann Med 2003; 35: 12-20.
  • V Sriraman, E. Niu, JR Matias, PK. Donahoe, DT MacLaughlin, MP Hardy et al. Müllerian inhibiting substance inhibits testosterone synthesis in adult rats. J Androl 2001; 22: 750-8.
  • Salhi I, Cambon-Roques S, Lamarre I, Laune D, Molina F, Pugnière M et al. Th e anti-Müllerian hormone type II receptor: insights into the binding domains recognized by a monoclonal antibody and the natural ligand. Biochem J 2004; 379: 785-93.
  • Kevenaar ME, Th emmen AP, Rivadeneira F, Uitterlinden AG, Laven JS, van Schoor NM et al. A polymorphism in the AMH type II receptor gene is associated with age at menopause in interaction with parity. Hum Reprod 2007; 22: 2382-8.
  • Bédécarrats GY, O’Neill FH, Norwitz ER, Kaiser UB, Teixeira J. Regulation of gonadotropin gene expression by Mullerian inhibitingsubstance. Proc Natl Acad Sci USA 2003; 100: 9348- 53.
Primary Language tr
Subjects
Journal Section Articles
Authors

Author: Turan AKDAĞ

Author: Ali Muhtar TİFTİK

Author: Levent SARIYILDIZ

Bibtex @ { tbtkmedical147103, journal = {Turkish Journal of Medical Sciences}, issn = {1300-0144}, eissn = {1303-6165}, address = {TUBITAK}, year = {2012}, volume = {42}, pages = {411 - 415}, doi = {}, title = {A comparative investigation of anti-Müllerian hormone (AMH) and various biochemical parameters in patients with cryptorchidism, oligospermia, or varicocele*}, key = {cite}, author = {AKDAĞ, Turan and TİFTİK, Ali Muhtar and SARIYILDIZ, Levent} }
APA AKDAĞ, T , TİFTİK, A , SARIYILDIZ, L . (2012). A comparative investigation of anti-Müllerian hormone (AMH) and various biochemical parameters in patients with cryptorchidism, oligospermia, or varicocele*. Turkish Journal of Medical Sciences, 42 (3), 411-415. Retrieved from http://dergipark.org.tr/tbtkmedical/issue/12298/147103
MLA AKDAĞ, T , TİFTİK, A , SARIYILDIZ, L . "A comparative investigation of anti-Müllerian hormone (AMH) and various biochemical parameters in patients with cryptorchidism, oligospermia, or varicocele*". Turkish Journal of Medical Sciences 42 (2012): 411-415 <http://dergipark.org.tr/tbtkmedical/issue/12298/147103>
Chicago AKDAĞ, T , TİFTİK, A , SARIYILDIZ, L . "A comparative investigation of anti-Müllerian hormone (AMH) and various biochemical parameters in patients with cryptorchidism, oligospermia, or varicocele*". Turkish Journal of Medical Sciences 42 (2012): 411-415
RIS TY - JOUR T1 - A comparative investigation of anti-Müllerian hormone (AMH) and various biochemical parameters in patients with cryptorchidism, oligospermia, or varicocele* AU - Turan AKDAĞ , Ali Muhtar TİFTİK , Levent SARIYILDIZ Y1 - 2012 PY - 2012 N1 - DO - T2 - Turkish Journal of Medical Sciences JF - Journal JO - JOR SP - 411 EP - 415 VL - 42 IS - 3 SN - 1300-0144-1303-6165 M3 - UR - Y2 - 2019 ER -
EndNote %0 Turkish Journal of Medical Sciences A comparative investigation of anti-Müllerian hormone (AMH) and various biochemical parameters in patients with cryptorchidism, oligospermia, or varicocele* %A Turan AKDAĞ , Ali Muhtar TİFTİK , Levent SARIYILDIZ %T A comparative investigation of anti-Müllerian hormone (AMH) and various biochemical parameters in patients with cryptorchidism, oligospermia, or varicocele* %D 2012 %J Turkish Journal of Medical Sciences %P 1300-0144-1303-6165 %V 42 %N 3 %R %U
ISNAD AKDAĞ, Turan , TİFTİK, Ali Muhtar , SARIYILDIZ, Levent . "A comparative investigation of anti-Müllerian hormone (AMH) and various biochemical parameters in patients with cryptorchidism, oligospermia, or varicocele*". Turkish Journal of Medical Sciences 42 / 3 (March 2012): 411-415.